ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2021

May 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2021-05-21

Reporting Person: FAVUS ELLIOT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-21	Common Stock	M	37500	$1.20	Acquired	37500	Direct
2021-05-21	Common Stock	M	50000	$.92	Acquired	87500	Direct
2021-05-21	Common Stock	M	1500	$5.64	Acquired	89000	Direct
2021-05-21	Common Stock	M	1500	$5.57	Acquired	90500	Direct
2021-05-21	Common Stock	M	1500	$4.90	Acquired	92000	Direct
2021-05-21	Common Stock	M	1500	$5.66	Acquired	93500	Direct
2021-05-21	Common Stock	M	1500	$6.11	Acquired	95000	Direct
2021-05-21	Common Stock	M	50000	$2.96	Acquired	145000	Direct
2021-05-21	Common Stock	S	145000	$11.6985	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-21	Stock Option (Right to Buy)	$1.20	M	37500	Disposed	2024-05-07	Common Stock (37500)	Direct
2021-05-21	Stock Option (Right to Buy)	$.92	M	50000	Disposed	2025-04-02	Common Stock (50000)	Direct
2021-05-21	Stock Option (Right to Buy)	$5.64	M	1500	Disposed	2025-09-30	Common Stock (1500)	Direct
2021-05-21	Stock Option (Right to Buy)	$5.57	M	1500	Disposed	2025-12-31	Common Stock (1500)	Direct
2021-05-21	Stock Option (Right to Buy)	$4.90	M	1500	Disposed	2026-03-31	Common Stock (1500)	Direct
2021-05-21	Stock Option (Right to Buy)	$5.66	M	1500	Disposed	2026-04-27	Common Stock (1500)	Direct
2021-05-21	Stock Option (Right to Buy)	$6.11	M	1500	Disposed	2026-06-30	Common Stock (1500)	Direct
2021-05-21	Stock Option (Right to Buy)	$2.96	M	50000	Disposed	2030-01-06	Common Stock (50000)	Direct